BPC-157 / TB500 20mg
BPC-157/TB-500 Combination 10mg
This dual-peptide formulation includes 10mg of BPC-157 and 10mg of TB-500, resulting in a synergistic 10mg lyophilized blend. These peptides are frequently studied for their regenerative and anti-inflammatory properties. Together, they are commonly used in research focused on accelerating healing, supporting musculoskeletal recovery, and enhancing cellular repair mechanisms.
BPC-157/TB-500 Research Based Benefits
- May assist in studies on soft tissue regeneration and wound healing
- Known for potential anti-inflammatory activity in tendon, muscle, and ligament research
- Could support angiogenesis and blood flow studies related to recovery
- May benefit research on gastrointestinal repair and systemic healing
- Useful in examining synergistic cellular regeneration pathways
Molecular Formulas
-
BPC-157: C62H98N16O22
-
TB-500: C212H350N56O78S
Product Features
- Total 10mg lyophilized powder: 10mg BPC-157 + 10mg TB-500
- Research-grade dual peptide blend for advanced scientific study
- Convenient single-vial formulation for efficient use
- Ideal for studies focused on recovery, inflammation, and tissue healing
- Securely packaged for safe handling and stability
BPC‑157
Preclinical Healing & Regeneration Studies:
- Tendon healing (rats): Accelerated outgrowth of tendon fibroblasts, improved cell survival and migration via FAK-paxillin pathway in Achilles tendon explants
- Nerve & soft tissue recovery (rodents): Improved functional recovery and neuroprotection in sciatic nerve transection and brain injury models
- Mechanistic overview: MDPI review emphasizes its angiogenic, anti-inflammatory, and safety profiles across diverse preclinical injury models
TB‑500
Wound Healing & Regeneration Evidence:
- Skin wound model: Topical or IP Tβ4 increased re-epithelialization by 42–61% and collagen deposition in full-thickness wounds
- Dermal repair across models: Accelerated healing in steroid-treated, diabetic, and aged rodents via enhanced tissue regeneration
- Clinical phase II: Improved healing in pressure ulcers, stasis ulcers, and epidermolysis bullosa patients
- Recent white paper summary: Acceleration of wound closure, tissue regeneration, and corneal/diabetic wound improvements described
Safety Disclaimer
This product is intended for research purposes only. It is not intended for human consumption or medical use.
